The key to Athira Pharma’s approach to Alzheimer’s disease is already inside each of us: a repair mechanism that can regenerate damaged neurons. What’s needed to begin the process is a pharmacological kickstart. Athira (NASDAQ: ATHA) is developing a drug intended to turn on the repair pathway. The company’s experimental therapy is a small molecule […]

The companies are requesting an approval for RLF-100 (aviptadil) as a treatment for COVID-19 patients who are receiving intensive care and who have exhausted all approved treatments. The EUA submission is based on a 51-person study that compared RLF-100 to those receiving maximal standard-of-care treatment in the same intensive care unit by the same medical […]

This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients. Topics on the show include the emergence of personalized medicine and breakthroughs in genomics advances in biopharmaceuticals age related diseases and aging in place using big data from wearables and sensors transparency in the medical […]